MedTrace Logo

Validation of the Gendolcat Score for the Prognosis of Chronic Postoperative Pain in Cesarean Section

NCT05739747 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 371

Last updated 2023-07-25

No results posted yet for this study

Summary

Chronic post-surgical pain is a problem that has historically been underestimated. Over the last few years there has been a search for strategies to both predict and prevent its occurrence in patients undergoing surgery. The Gendolcat index is the only predictive model that uses only objective pre-surgical variables to assess the risk of suffering chronic post-surgical pain. However, it is only validated for the following surgeries: thoracotomy, hysterectomy and open inguinal hernia. Our aim is to test whether the Gendolcat model is also valid for cesarean section.

Conditions

  • Chronic Post Surgical Pain
  • Cesarean Section Complications
  • Chronic Pain

Interventions

OTHER

Questionnaire

All patients should complete the following questionnaires: On the day of surgery: * Patient registration. * Complete medical history. * Gendolcat scale (including the Spanish version of the SF-12 scale). * Spanish version of the catastrophizing scale.

OTHER

Questionnaire

The investigators should complete a questionnaire during the surgical procedure specifying the anesthetic technique used, drugs and doses used and record any incident during the surgical procedure

OTHER

Questionnaire

The investigators should complete a questionnaire 24 hours after surgery to assess the possible presence of postoperative pain as well as the intensity and need for rescue analgesia.

OTHER

Questionnaire via telephone call

At 3 months, patients will be called and a structured questionnaire will be completed to assess the presence of chronic postoperative pain.

OTHER

Physical examination

Those women who, after the telephone call, are considered to have chronic post-surgical pain will undergo a physical examination to confirm it. The type of pain and its intensity will also be evaluated. The impact on their daily physical activity and quality of life will be evaluated by means of a questionnaire.

Sponsors & Collaborators

  • Consorci Sanitari de Terrassa

    lead OTHER

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-04-01
Primary Completion
2024-02-29
Completion
2025-02-28

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05739747 on ClinicalTrials.gov